SIR,-Dr Miller and his colleagues (July 1989; 44:565-9) report that nebulised pentamidine when delivered by a Respirgard II nebuliser is more effective in the treatment of Pneumocystis carinii pneumonia than when delivered by an Acorn nebuliser.
They state, however, that the mass median aerodynamic diameter (MMAD) of the aerosol produced by the Acorn is 2-6 pm. This means that 50% ofthe aerosol mass is contained in droplets ofless than 2-6 pm and 50% of the aerosol mass is contained in droplets of 2-6 pm or more. It is therefore a physical impossibility for 46% of the particles to be less than 3 9 pm, as the authors state. If this latter figure is correct, then the MMAD of the aerosol must be 3 9 pm or more. The correct size of the aerosol is critical to the interpretation of this study. Newman with saline, and an MMAD of 2-6 pm and GSD of 2-9 with pentamidine (100 mg/ml). The group quoted by Dr Summers report that an Acorn nebuliser running at 8 1/min nebulising saline produces an MMAD of 2-3 pm and not 4 5-5 7 pm.' We report four patients from group 2 with bronchial oozing and a further patient with bronchial oozing and haemoptysis and in group 1 two patients with ooze and a further patient with ooze and haemoptysis. Unfortunately, with editorial pruning details of the bronchial bleeding have been lost. We in fact described bronchial oozing as the bronchoscope was being positioned in peripheral bronchi before bronchoalveolar lavage.2 In the patients in whom we reported bronchial bleeding pentamidine had been started pending the bronchoscopic result. At the time of bronchoscopy one patient had received six doses of pentamidine, two patients four doses, one patient two doses, and a further patient a single dose of pentamidine (group 2 patients). In group 1 patients one patient had received three doses, one two doses, and one a single dose ofpentamidine at the time of bronchoscopy. Our explanation for this apparent difference in incidence of side effects is that possibly the Acorn, because of the greater heterodispersity of aerosol droplets, in fact enables a smaller proportion of the delivered dose to reach the peripheral airways and so cause the local toxic effect. The terms sensitivity and specificity of a diagnostic test were introduced by Jacob Yerushalmy' in an epidemiological setting when the diagnosis of the patient was known and the accuracy of the test was evaluated in retrospect. This type of sensitivity and specificity, subsequently called nosological,2 is of limited direct value in diagnosis when the patient presents with a finding or group of findings and the test is used to help confirm or exclude a diagnosis.23 In these circumstances the diagnostic specificity (positive predictive value) and sensitivity (negative predictive value) are more appropriate. When the test is applied in clinical practice these values can be 831
